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Acneiform dermatoses are follicular eruptions. The initial lesion is inflamma-
tory, usually a papule or pustule. Comedones are later secondary lesions, a
sequel to encapsulation and healing of the primary abscess. The earliest histo-
logical event is spongiosis, followed by a break in the follicular epithelium. The
spilled follicular contents provokes a nonspecific lymphocytic and neutrophilic
infiltrate. Acneiform eruptions are almost always drug induced. Important clues
are sudden onset within days, widespread involvement, unusual locations (fore-
arm, buttocks), occurrence beyond acne age, monomorphous lesions, sometimes
signs of systemic drug toxicity with fever and malaise, clearing of inflammatory
lesions after the drug is stopped, sometimes leaving secondary comedones.
Other cutaneous eruptions that may superficially resemble acne vulgaris but that
are not thought to be related to it etiologically are due to infection (e.g. gram-
negative folliculitis) or unknown causes (e.g. acne necrotica or acne aestivalis).
oooooooooooooooooooo
Introduction
The term ‘acneiform’ refers to conditions which super-
ficially resemble acne vulgaris but are not thought to be re-
lated to it etiologically.
Acneiform eruptions are follicular reactions beginning
with an inflammatory lesion, usually a papule or pustule.
Comedones are uncommon and usually follow pustules.
These follicular inflammatory responses are almost always
induced by drugs, but they are occasionally due to infection
(e.g. gram-negative folliculitis) or unknown cause (e.g.
acne necrotica or acne aestivalis).
Drug-Induced Acne
Certain drugs are capable of aggravating preexisting
acne or of inducing acne fulminans and acneiform erup-
tions in predisposed subjects, similar in distribution to acne
vulgaris but often of acute onset and predominantly inflam-
matory (acne medicamentosa) [1]. The diagnosis of an ac-
neiform eruption should be considered if the lesions are
seen in an unusual localization for acne, e.g. involvement of
distal parts of the extremities (table 1). In contrast to acne
vulgaris, which always begins with faulty keratinization
in the infundibula (microcomedones), comedones are usu-
ally absent or may develop secondarily. Sometimes signs
of systemic drug toxicity such as fever and malaise are
present.
The substances responsible for acneiform eruptions are
corticosteroids (steroid acne) [2] (fig.1), anabolic steroids
including danazole [3] and testosterone (bodybuilding
acne, doping acne), corticotropin [4], tetracyclines [5],
vitamins B1, B6 [6], B12 [7], and D2, anticonvulsants [8],
psychopharmacologic drugs, e.g. lithium carbonate [9] or
amineptine [10], isoniazid [11], quinidine [12], azathio-
prine [13], cyclosporine A [14], etretinate [15], penicil-
lamine, iodides and bromides (halogen acne) [16]. Some
drugs such as testosterone and anabolic drugs may even in-
duce acne fulminans [17]. Although 13-cis-retinoic acid is
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used in the treatment of severe acne, paradoxically this
drug is reported to cause acne fulminans as an adverse ef-
fect [18]. In most cases the exact pathogenesis of acne
medicamentosa remains unknown.
Acneiform eruptions are nonallergic reactions that do
not appear to have a single mechanism. Therefore skin test-
ing is not useful in diagnosing drug-induced acne. The pa-
tient’s history, the clinical findings, the exposure to one of
the known causative drugs and the disappearance of lesions
after discontinuation of the offending medication should
lead to the diagnosis.
For example, steroid acne appears to result from a direct
effect of the steroid on the follicular epithelium, causing
a focal degeneration with a localized intrafollicular and
perifollicular neutrophilic inflammatory reaction (fig.2–4)
[2]. It is assumed that large lesions do not occur because
of the anti-inflammatory effect of the steroid itself. Also,
unlike acne vulgaris, follicular hyperkeratosis is not an
early event, as was once believed [19].
An acneiform eruption may be observed following the
prolonged systemic administration of iodides or bromides
[16, 20, 21]. It is important to note that halogens may be
present in unsuspected sources, e.g. iodides in drugs used
for the treatment of colds and asthma, radioopaque contrast
materials and vitamin-mineral preparations, or bromides in
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Fig. 1. Steroid acne from oral intake of
prednisolone. Widespread uniform papulo-
pustules cover most of the back, wherever
there are sebaceous follicles.
Fig. 2. Steroid acne. The earliest de-
tectable event is a focal necrosis of the mid-
portion of the infundibulum of the sebaceous
follicle. There is no comedo. Lymphocytes
and some granulocytes are at the breach.
Hematoxylin and eosin stain.
Table 1. Characteristics of drug-induced acne
Sudden onset
Widespread extent from the beginning
Monomorphous appearance
Unusual localizations for acne, e.g. involvement of distal extremities
Unusual age for acne vulgaris
Exposure to drug
Fig. 3. Steroid acne. Advanced stage of comedo formation. This is
a closed comedo, with colonization of bacteria, keratinization of the
sebaceous duct and involution of the sebaceous glands. Hematoxylin
and eosin stain.
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sedatives, analgesics and cold remedies. Fad diets with high
iodide supplementation, such as large quantities of kelp
pills [22], seem to be related to flares of preexisting acne.
Bodybuilding acne (doping acne, power athlet acne) is a
popular variant of androgen-induced acne [17]. It is most
common in bodybuilders and weight lifters who have a
history of oral or parenteral intake of anabolic-androgenic
steroids and vitamin B complexes. Often there is no history
of previous acne. These patients may show mild to severe
acne, even acne fulminans, oily skin and hair, androgenic
alopecia of the scalp, hirsutism of the face and body, and
gynecomastia. Extracutaneous side effects of anabolic-an-
drogenic steroids, e.g. changes in libido, increased aggres-
siveness, mood swings (euphoria, depression, delusions),
liver disease (peliosis or cholestatic hepatitis, liver tumors)
or cardiovascular disorders (e.g. cardiomyopathy) may also
be present.
Drugs which cause acneiform eruptions can, at the same
time, aggravate a preexisting acne. In these cases, underly-
ing acne with a sudden worsening is mixed with additional
crops of acneiform eruptions.
Gram-Negative Folliculitis
This is a follicular pyoderma and not a variant of acne,
but it is a characteristic complication of long-term oral
antibiotic acne treatment [23, 24]. Gram-negative folliculitis
occurs in patients who have had moderately inflammatory
acne for long periods and have been treated with long-term
antibiotics, especially tetracyclines. At first antibiotics,
mainly tetracyclines, provide adequate control. Later on,
the drug not only becomes ineffective but actually makes
the condition worse.
Two types of gram-negative folliculitis have been de-
scribed [25]. While on antibiotic treatment, patients de-
velop either papules and papulopustules 3–6 mm in diame-
ter flaring out from the anterior nares (type I; fig.5) or, on
rare occasions, fluctuant, deep-seated, acne-conglobata-like
nodules (type II). Culture of these lesions usually reveals
a species of Enterobacter, Klebsiella or Escherichia coli
(type I) or, from the deep cystic lesions, Proteus (type II).
With long-term antibiotic therapy the anterior nares may
become colonized with these gram-negative organisms. Im-
munological factors may contribute to the pathogenesis
of this disease [26]. Organisms are often scarce and their
detection may require sampling several lesions. Problems
often arise in establishing a correct microbiological diagno-
sis. Inadequate sampling, dried-out swabs and long delay
between culturing the pustules and arrival of the specimen
in the laboratory are factors which may account for this.
Systemic treatment with isotretinoin (0.5–1.0 mg/kg
daily) for 4–5 months is usually effective [27, 28]. The
mode of action of isotretinoin is indirect. Gram-negative
organisms are wet germs and normally require abundant
moisture for survival. Isotretinoin dries out the skin, taking
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Fig. 4. Steroid acne. Later stage of a secondary comedo following
an initial follicular rupture. Asymmetry is an important clue. Hema-
toyxlin and eosin stain.
Fig. 5. Type I gram-negative folliculitis is caused by a variety of
gram-negative organisms. Papules and pustules are found particularly
around the nose, mouth and cheeks on extremely oily skin.4
5
away this essential factor for the survival of these bacteria.
This also happens in the mucous membranes but not to
the same degree. In selected patients, oral antibiotics
(cephalosporins) for 2 weeks may have to be combined
with isotretinoin, which is given for several months. Simul-
taneous colonization of the urogenital tract, mostly without
clinical symptoms such as prostatitis, with gram-negative
organisms has been detected in some of our patients. Oral
isotretinoin alone does not seem to cure these infections.
Particularly in these patients isotretinoin plus an oral anti-
biotic seem appropriate.
Acne necrotica
Acne necrotica (synonyms are acne necrotica miliaris,
acne varioliformis, acne frontalis, acne atrophica, pustular
perifolliculitis, necrotizing lymphocytic folliculitis) is an
uncommon papulopustular, follicular eruption that even-
tually leaves depressed superficial scars resembling small-
pox scars, hence the previous term acne varioliformis [29].
The disease occurs after puberty without sexual predilec-
tion.
The etiology is essentially unknown. Although coagu-
lase-positive staphylococci have been cultured from the
pustules, the importance of this organism is difficult to
assess. Propionibacterium acnes has also been implicated
[30]. Some clinicians doubt the existence of this condition
as a distinct entity.
The process begins as a brown-red, grouped, papulopus-
tular perifollicular lesion (fig.6). As the pustules increase
in size, their centers become depressed and a dry crust de-
velops that is frequently hemorrhagic. This is the pap-
ulonecrotic lesion. The resulting scar is also depressed and
varioliform. If the lesions are recurrent, the resulting scar
may be reticulated. The typical distribution and morphol-
ogy of scarring is a lifelong evidence of previous acne
necrotica. Lesions are located most often at the temporal
area of the scalp [31] but have been described on the nose,
cheek, chest and back. Patients with the disease often suffer
from seborrhea. The folliculitis is frequently accompanied
by intense itching.
The earliest lesion is an intraepidermal vesicle filled
with serum [32]. Later, a superficial follicular pustule filled
with polymorphonuclear leukocytes is found (fig.7). At the
opening of the follicle a crust made up of serum and clumps
of bacteria may be present. A lymphocytic infiltrate occurs
limited to the perifollicular area, and some neutrophils may
be seen migrating the follicular wall. Healing with fibrosis
and scar formation often results [33].
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Fig. 6. Acne necrotica. Typical distribu-
tion pattern along the hairline, with wide-
spread involvement of the hairy scalp. Scar-
ring on the forehead is a result of previous
acne.
Fig. 7. Acne necrotica. A wedge-shaped central necrosis, totally
obscuring the original follicle, prevails. A parakeratotic cap sits on top
of a fibrinoid necrosis. The lymphocytic infiltrate is dense, stretching
out bilaterally to cause prominent spongiosis of epidermis and neigh-
boring follicles. Hematoxylin and eosin stain.
Bacterial cultures and sensitivity studies are generally
not helpful as treatment guides. Routine aerobic cultures
invariably grow Staphylococcus epidermidis or sometimes
Staphylococcus aureus. Gram staining may demonstrate
numerous intracellular and extracellular gram-positive
pleomorphic rods compatible with P. acnes.
Systemic antibiotics as for acne should be initiated
[34, 35]. Tetracycline, 250 mg four times daily, or erythro-
mycin in a similar dosage is appropriate. In our experience, a
therapeutic regimen including isotretinoin (0.5–1.0 mg/kg)
combined with corticosteroids, e.g. 0.5–1.0 mg/kg of pred-
nisolone, may also be effective. Additional measures such
as antibacterial washes, e.g. chlorhexidine or hexachloro-
phene, and warm wet compresses to loosen the crusts may
be helpful. A topical corticosteroid lotion or aerosol helps
alleviate pruritus. Treatment must usually be prolonged
for weeks or months. Once control has been achieved, an-
tibacterial lotions such as clindamycin 1% or erythromycin
2% may be substituted for systemic antibiotics or iso-
tretinoin. Daily shampooing, the use of antibacterial cleans-
ers and topical antibiotic therapy may be of value for pro-
phylaxis.
Acne aestivalis
Acne aestivalis (Mallorca acne) refers to a monomor-
phous eruption, consisting of multiple papular lesions,
which has been reported to develop after sun exposure
(fig.8). Hjorth et al. [36] referred to this as Mallorca acne
since it occurred in many Scandinavians after they had been
on a sunny vacation in Mallorca after a long dark winter.
Although the cheeks may be involved, the lesions com-
monly extend onto the sides of the neck, chest, shoulders
and upper arms. The last location is rare in ordinary acne.
Histologically, the lesions resemble steroid acne in that they
show a focal follicular destruction with neutrophilic infil-
trate. Comedones are notably not apparent as are pustules.
The disease may abate after many months, probably be-
cause of less intensive sunbathing. The eruption is due to
the effects of UV radiation, mainly UVA. Similar follicular
eruptions have also been reported as an unusual side effect
of photochemotherapy (PUVA) [37]. Like patients with
polymorphous light reaction, subjects prone to acne aesti-
valis react the same way year after year. Indeed, there is
some evidence that this is a papular variant of polymor-
phous light eruption.
While oral antibiotics are ineffective, topical tretinoin or
benzoyl peroxide is valuable in bringing about resolution of
lesions. Topical corticosteroids should be avoided, since
they may aggravate the disease. Prophylaxis can be offered
by gradually increasing exposure to full-body artificial UV
radiation, UVB or UVA, either alone or in combination, or
even PUVA therapy prior to the first exposure to natural
sunlight.
106 Dermatology 1998;196:102–107 Plewig/Jansen
Fig. 8. Acne aestivalis. The lesions are monomorphic, follicular
papules containing a small central core of horn with a surrounding 
inflammatory reaction.
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